Rocket Pharmaceuticals 2023 J.P. Morgan Healthcare Conference Presentation

Rocket Pharmaceuticals presented at the 41st Annual J.P. Morgan Healthcare Conference in January 2023, showcasing its pipeline of first-in-class and best-in-class gene therapies for rare genetic diseases including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease. The company outlined its strategic vision and 2023 guidance while addressing the ongoing impact of COVID-19 on clinical trials and operations.